Deborah Ovadia
About Deborah Ovadia
Deborah Ovadia serves as the Director of Alliance Management at Sangamo Therapeutics, where she focuses on managing partnered programs in neuroscience and rare blood diseases. She has a strong background in biochemistry and extensive experience in alliance management and clinical operations from her previous roles at Gilead Sciences and Clovis Oncology.
Current Role at Sangamo Therapeutics
Deborah Ovadia serves as the Director of Alliance Management at Sangamo Therapeutics, Inc. since 2020. In this role, she enhances the organization's Alliance Management capability by assessing partnering competencies and providing training in best practices. She is responsible for negotiating contracts and identifying new opportunities for partnership expansion. Ovadia manages partnered programs specifically focused on neuroscience and rare blood diseases, aligning internal stakeholders and external partners to achieve program goals.
Previous Experience at Gilead Sciences
Deborah Ovadia worked at Gilead Sciences, Inc. for a total of eight years. She held the position of Manager, Clinical/Medical Affairs Operations from 1998 to 2004, where she contributed to operational management in clinical and medical affairs. Following this role, she served as Senior Manager, International Access Ops from 2005 to 2007, focusing on international access strategies. Her experience at Gilead Sciences provided her with a solid foundation in the biopharmaceutical industry.
Experience at Clovis Oncology
From 2015 to 2020, Deborah Ovadia worked at Clovis Oncology in Project Leadership. During her five years in this role, she contributed to the management of various projects within the organization. Her experience in the San Francisco Bay Area allowed her to engage with a dynamic biotechnology environment, further enhancing her expertise in project management and collaboration.
Educational Background
Deborah Ovadia studied at Texas A&M University, where she earned a Master of Science (MS) in Biochemistry. Additionally, she attended the College of Charleston, achieving both a Bachelor of Science (BS) in Biochemistry and a Bachelor of Arts (BA) in French. Her educational background provides her with a strong foundation in both scientific and linguistic disciplines.